Casi Pharmaceuticals Inc (CASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 24 | 0 | 669 | 1,941 | 3,693 |
| Cost of Goods | 8 | N/A | N/A | N/A | N/A |
| Gross Profit | 16 | N/A | 669 | 1,941 | 3,693 |
| Operating Expenses | 26,211 | 5,740 | 5,173 | 6,509 | 11,228 |
| Operating Income | -26,188 | -5,740 | -4,504 | -4,568 | -7,535 |
| Interest Expense | 27 | 2 | 10,041 | 0 | 540 |
| Other Income | 12 | 3 | 0 | 10 | -26 |
| Pre-tax Income | -26,202 | -5,738 | -14,545 | -4,559 | -8,101 |
| Net Income Continuous | -26,202 | -5,738 | -14,545 | -4,559 | -8,101 |
| Net Income | $-26,202 | $-5,738 | $-14,545 | $-4,559 | $-8,101 |
| EPS Basic Total Ops | -9.20 | -2.20 | -7.80 | -4.70 | -9.40 |
| EPS Basic Continuous Ops | -9.16 | -2.20 | -7.63 | -3.87 | -8.37 |
| EPS Diluted Total Ops | -9.20 | -2.20 | -7.80 | -4.70 | -9.40 |
| EPS Diluted Continuous Ops | -9.16 | -2.20 | -7.63 | -3.87 | -8.37 |
| EBITDA(a) | $-26,139 | $-5,723 | $-4,484 | $-4,530 | $-7,464 |